A J&J Medication Reduces Symptoms Of Sadness And Sleeplessness In A Late-Stage Research
In a late-stage trial, Johnson & Johnson’s experimental medication helped patients with major depressive disorder (MDD) experience less sleeplessness and depression symptoms, the firm stated in a statement. Seltorexant was the medication being tested in this research on individuals who suffered from both sleeplessness and depression. Even with the usage of widely prescribed antidepressant medications,…









